International Journal of Molecular Sciences · 2020 · 22 citations · 37 references
MedicineOncologyPharmacologyApoptosisChemotherapyGlial BiologyGastrointestinal InflammationGastrointestinal PathophysiologyGastrointestinal PharmacologyGastrointestinal ToxicityIncretin-based TherapiesIntestinal Barrier FunctionColonic PathologyDrug-induced Mucosal InjuryGastrointestinal Barrier DysfunctionGastrointestinal Mucosal DamageGlucagon-like PeptidesIntestinal Mucosal InjuryMucosal Barrier IntegrityMucosal Tissue Damage
Cisplatin is a chemotherapeutic agent widely used for the treatment of solid cancers. Its administration is commonly associated with acute and chronic gastrointestinal dysfunctions, likely related to mucosal and enteric nervous system (ENS) injuries, respectively. Glucagon-like peptide-2 (GLP-2) is a pleiotropic hormone exerting trophic/reparative activities on the intestine, via antiapoptotic and pro-proliferating pathways, to guarantee mucosal integrity, energy absorption and motility. Further, it possesses anti-inflammatory properties. Presently, cisplatin acute and chronic damages and GLP-2 protective effects were investigated in the mouse distal colon using histological, immunohistochemical and biochemical techniques. The mice received cisplatin and the degradation-resistant GLP-2 analog ([Gly2]GLP-2) for 4 weeks. Cisplatin-treated mice showed mucosal damage, inflammation, IL-1β and IL-10 increase; decreased number of total neurons, ChAT- and nNOS-immunoreactive (IR) neurons; loss of SOX-10-IR cells and reduced expression of GFAP- and S100β-glial markers in the myenteric plexus. [Gly2]GLP-2 co-treatment partially prevented mucosal damage and counteracted the increase in cytokines and the loss of nNOS-IR and SOX-10-IR cells but not that of ChAT-IR neurons. Our data demonstrate that cisplatin causes mucosal injuries, neuropathy and gliopathy and that [Gly2]GLP-2 prevents these injuries, partially reducing mucosal inflammation and inducing ENS remodeling. Hence, this analog could represent an effective strategy to overcome colonic injures induced by cisplatin.
37
Palle Bekker Jeppesen, Richard Gilroy, M. Pertkiewicz et al. · Gut · 2011 · 451 citations · Full text
Agriculture, Nutrition, Pharmacology +17
Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system
Werend Boesmans, Reena Lasrado, Pieter Vanden Berghe et al. · Glia · 2014 · 271 citations · Full text
Medicine, Neurobiology, Neuroscience +14
Daniel J. Drucker, Bernardo Yusta, Robin P. Boushey et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 1999 · 174 citations